SE452009B - 6-substituerade 6h-dibenso/b,d/pyranderivat, forfarande for deras framstellning samt farmaceutisk komposition innehallande nemnda derivat - Google Patents
6-substituerade 6h-dibenso/b,d/pyranderivat, forfarande for deras framstellning samt farmaceutisk komposition innehallande nemnda derivatInfo
- Publication number
- SE452009B SE452009B SE8106167A SE8106167A SE452009B SE 452009 B SE452009 B SE 452009B SE 8106167 A SE8106167 A SE 8106167A SE 8106167 A SE8106167 A SE 8106167A SE 452009 B SE452009 B SE 452009B
- Authority
- SE
- Sweden
- Prior art keywords
- dibenzo
- pyran
- methyl
- hydroxy
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 38
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 230
- -1 ethyl-substituted piperidyl group Chemical group 0.000 claims description 168
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 claims description 120
- 229910052739 hydrogen Inorganic materials 0.000 claims description 75
- 239000001257 hydrogen Substances 0.000 claims description 73
- 239000000203 mixture Substances 0.000 claims description 42
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 40
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 150000002431 hydrogen Chemical class 0.000 claims description 38
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 37
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 32
- 238000011282 treatment Methods 0.000 claims description 26
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 23
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 20
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims description 17
- 239000000460 chlorine Substances 0.000 claims description 15
- 229910052783 alkali metal Inorganic materials 0.000 claims description 14
- 229910052705 radium Inorganic materials 0.000 claims description 14
- 229910052701 rubidium Inorganic materials 0.000 claims description 14
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 13
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 12
- 150000002367 halogens Chemical class 0.000 claims description 12
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 12
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 11
- 229910052801 chlorine Inorganic materials 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 125000006239 protecting group Chemical group 0.000 claims description 8
- 235000012000 cholesterol Nutrition 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 239000011737 fluorine Substances 0.000 claims description 6
- 229910052731 fluorine Inorganic materials 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 238000007363 ring formation reaction Methods 0.000 claims description 6
- 238000002560 therapeutic procedure Methods 0.000 claims description 6
- ZQNSZNXHWQJCAK-UHFFFAOYSA-N (2-methoxy-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 ZQNSZNXHWQJCAK-UHFFFAOYSA-N 0.000 claims description 5
- AEGGBXJLMMKVEI-UHFFFAOYSA-N 2-chloro-6-methylbenzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C(C)(C(O)=O)OC3=CC=C(Cl)C=C3C2=C1 AEGGBXJLMMKVEI-UHFFFAOYSA-N 0.000 claims description 5
- YLGSBQPQENHHDS-UHFFFAOYSA-N 6-methylbenzo[c]chromene-6-carbonitrile Chemical compound C1=CC=C2C(C)(C#N)OC3=CC=CC=C3C2=C1 YLGSBQPQENHHDS-UHFFFAOYSA-N 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- WDWLAWGHTXZJNS-UHFFFAOYSA-N ethyl 2-(4aH-benzo[c]chromen-6-yl)acetate Chemical compound C(C)OC(=O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 WDWLAWGHTXZJNS-UHFFFAOYSA-N 0.000 claims description 4
- XLGFZPLLZBWTNP-UHFFFAOYSA-N ethyl 3-(2-fluoro-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 XLGFZPLLZBWTNP-UHFFFAOYSA-N 0.000 claims description 4
- RADDJWUYJCISRB-UHFFFAOYSA-N ethyl 3-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC RADDJWUYJCISRB-UHFFFAOYSA-N 0.000 claims description 4
- 125000004193 piperazinyl group Chemical group 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- QULGJHLMOUBVQD-UHFFFAOYSA-N (8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC QULGJHLMOUBVQD-UHFFFAOYSA-N 0.000 claims description 3
- MRQWUADQIMIYCZ-UHFFFAOYSA-N 1-methyl-4aH-benzo[c]chromen-6-amine Chemical compound NC1=C2C(=C3C(O1)C=CC=C3C)C=CC=C2 MRQWUADQIMIYCZ-UHFFFAOYSA-N 0.000 claims description 3
- QQLXHTCAMMRXCE-UHFFFAOYSA-N 2-(1-methoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2 QQLXHTCAMMRXCE-UHFFFAOYSA-N 0.000 claims description 3
- RSWULKOIAXFEBO-UHFFFAOYSA-N 2-(2-chloro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 RSWULKOIAXFEBO-UHFFFAOYSA-N 0.000 claims description 3
- DKMKBRUIEYBDBF-UHFFFAOYSA-N 2-(2-methoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 DKMKBRUIEYBDBF-UHFFFAOYSA-N 0.000 claims description 3
- NAYXHONJVIWQTJ-UHFFFAOYSA-N 2-(2-nitro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 NAYXHONJVIWQTJ-UHFFFAOYSA-N 0.000 claims description 3
- OSLYOSBFYXMGCH-UHFFFAOYSA-N 2-(4ah-benzo[c]chromen-6-yl)acetic acid Chemical compound C1=CC=CC2OC(CC(=O)O)=C(C=CC=C3)C3=C21 OSLYOSBFYXMGCH-UHFFFAOYSA-N 0.000 claims description 3
- YLWZMRRIXRSMLG-UHFFFAOYSA-N 2-(8-chloro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)Cl YLWZMRRIXRSMLG-UHFFFAOYSA-N 0.000 claims description 3
- ZLIVKHHDHFCBKG-UHFFFAOYSA-N 2-(8-fluoro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F ZLIVKHHDHFCBKG-UHFFFAOYSA-N 0.000 claims description 3
- KVNYCQKWTWETTI-UHFFFAOYSA-N 2-(8-methoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)OC KVNYCQKWTWETTI-UHFFFAOYSA-N 0.000 claims description 3
- RARZFNNGJNNUDK-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-amino-4aH-benzo[c]chromene-6-carboxylate Chemical compound CN(CCOC(=O)C1=C2C(=C3C(O1)C=CC(=C3)N)C=CC=C2)C RARZFNNGJNNUDK-UHFFFAOYSA-N 0.000 claims description 3
- SBOUATARNOBLKH-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-amino-6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCCN(C)C)(C)OC3=CC=C(N)C=C3C2=C1 SBOUATARNOBLKH-UHFFFAOYSA-N 0.000 claims description 3
- VAJRCJHCRBQMFA-UHFFFAOYSA-N 2-(dimethylamino)ethyl 4aH-benzo[c]chromene-6-carboxylate Chemical compound CN(CCOC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2)C VAJRCJHCRBQMFA-UHFFFAOYSA-N 0.000 claims description 3
- WLLMAKBNRIDHGZ-UHFFFAOYSA-N 2-(dimethylamino)ethyl 6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCCN(C)C)(C)OC3=CC=CC=C3C2=C1 WLLMAKBNRIDHGZ-UHFFFAOYSA-N 0.000 claims description 3
- MBZHEZIRYJFAMC-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-chloro-4aH-benzo[c]chromen-6-yl)ethanol Chemical compound OC(CNC(C)(C)C)C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 MBZHEZIRYJFAMC-UHFFFAOYSA-N 0.000 claims description 3
- FPKMNRCRAABLMG-UHFFFAOYSA-N 3-(2-chloro-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 FPKMNRCRAABLMG-UHFFFAOYSA-N 0.000 claims description 3
- FBYYLFJDUPWLFR-UHFFFAOYSA-N 3-(4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 FBYYLFJDUPWLFR-UHFFFAOYSA-N 0.000 claims description 3
- HQANBWUZTFFASO-UHFFFAOYSA-N 4-(4aH-benzo[c]chromen-6-yl)piperidine Chemical compound N1CCC(CC1)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 HQANBWUZTFFASO-UHFFFAOYSA-N 0.000 claims description 3
- SEFMZHOARYMEQR-UHFFFAOYSA-N 6-(aminomethyl)-4aH-benzo[c]chromen-2-ol Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)O)C=CC=C2 SEFMZHOARYMEQR-UHFFFAOYSA-N 0.000 claims description 3
- MFPHECWJSYZMRG-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)O Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)O MFPHECWJSYZMRG-UHFFFAOYSA-N 0.000 claims description 3
- JSYKYPQFBMZXBT-UHFFFAOYSA-N CN(C)CCOC(=O)C1=C2C=CC=CC2=C3C=C(C=CC3O1)Cl Chemical compound CN(C)CCOC(=O)C1=C2C=CC=CC2=C3C=C(C=CC3O1)Cl JSYKYPQFBMZXBT-UHFFFAOYSA-N 0.000 claims description 3
- YMZUUWYQGIXQGK-UHFFFAOYSA-N CN(C)CCOC(=O)C1=C2C=CC=CC2=C3C=C(C=CC3O1)F Chemical compound CN(C)CCOC(=O)C1=C2C=CC=CC2=C3C=C(C=CC3O1)F YMZUUWYQGIXQGK-UHFFFAOYSA-N 0.000 claims description 3
- GERCXGRNRCSOJG-UHFFFAOYSA-N CN(C)CCOC(=O)CC1=C2C=CC=CC2=C3C=CC=CC3O1 Chemical compound CN(C)CCOC(=O)CC1=C2C=CC=CC2=C3C=CC=CC3O1 GERCXGRNRCSOJG-UHFFFAOYSA-N 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- RDWMLVIEHMPVOE-UHFFFAOYSA-N ethyl 2-chloro-6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)(C)OC3=CC=C(Cl)C=C3C2=C1 RDWMLVIEHMPVOE-UHFFFAOYSA-N 0.000 claims description 3
- YTTQOGOZQBPUOM-UHFFFAOYSA-N ethyl 3-(2-chloro-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 YTTQOGOZQBPUOM-UHFFFAOYSA-N 0.000 claims description 3
- QFCZMYJZELGOCE-UHFFFAOYSA-N ethyl 3-(6-methylbenzo[c]chromen-6-yl)propanoate Chemical compound C1=CC=C2C(CCC(=O)OCC)(C)OC3=CC=CC=C3C2=C1 QFCZMYJZELGOCE-UHFFFAOYSA-N 0.000 claims description 3
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 3
- XOPIRYPKEJPRLA-UHFFFAOYSA-N 1,10-dimethoxy-6-methylbenzo[c]chromene-6-carboxylic acid Chemical compound O1C(C)(C(O)=O)C2=CC=CC(OC)=C2C2=C1C=CC=C2OC XOPIRYPKEJPRLA-UHFFFAOYSA-N 0.000 claims description 2
- FOWDCBKFJNPSDG-UHFFFAOYSA-N 1-(1,10-dimethoxy-4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1(CCNCC1)C1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC FOWDCBKFJNPSDG-UHFFFAOYSA-N 0.000 claims description 2
- QIOIDCLMCBEBEI-UHFFFAOYSA-N 1-(2-chloro-4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1(CCNCC1)C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 QIOIDCLMCBEBEI-UHFFFAOYSA-N 0.000 claims description 2
- HOPPSOGNVFCRAH-UHFFFAOYSA-N 1-(2-nitro-4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1(CCNCC1)C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 HOPPSOGNVFCRAH-UHFFFAOYSA-N 0.000 claims description 2
- GQYDQYFKLUPGDU-UHFFFAOYSA-N 1-(4aH-benzo[c]chromen-6-yl)-2-(tert-butylamino)ethanol Chemical compound OC(CNC(C)(C)C)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 GQYDQYFKLUPGDU-UHFFFAOYSA-N 0.000 claims description 2
- QBVTWEZLAOCPQD-UHFFFAOYSA-N 1-methoxy-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2 QBVTWEZLAOCPQD-UHFFFAOYSA-N 0.000 claims description 2
- WHWCHJDHCQDSPC-UHFFFAOYSA-N 2-(2-fluoro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 WHWCHJDHCQDSPC-UHFFFAOYSA-N 0.000 claims description 2
- YPPHJKBBRWTSAF-UHFFFAOYSA-N 2-(8-nitro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)[N+](=O)[O-] YPPHJKBBRWTSAF-UHFFFAOYSA-N 0.000 claims description 2
- XSWBHGFPWPHCNM-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methoxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound CN(CCOC(=O)C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2)C XSWBHGFPWPHCNM-UHFFFAOYSA-N 0.000 claims description 2
- JHFHYTLSVGVYPA-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-nitro-4aH-benzo[c]chromene-6-carboxylate Chemical compound CN(CCOC(=O)C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2)C JHFHYTLSVGVYPA-UHFFFAOYSA-N 0.000 claims description 2
- PNKNKZPWNPFZFL-UHFFFAOYSA-N 2-(dimethylamino)ethyl 6-ethylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(CC)(C(=O)OCCN(C)C)OC3=CC=CC=C3C2=C1 PNKNKZPWNPFZFL-UHFFFAOYSA-N 0.000 claims description 2
- PQDDMQPNFRIJQI-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-methoxy-4aH-benzo[c]chromen-6-yl)ethanol Chemical compound OC(CNC(C)(C)C)C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 PQDDMQPNFRIJQI-UHFFFAOYSA-N 0.000 claims description 2
- HVLQEMLOZQZNOJ-UHFFFAOYSA-N 2-[2-(trifluoromethyl)-4aH-benzo[c]chromen-6-yl]acetic acid Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC(=C3)C(F)(F)F)C=CC=C2 HVLQEMLOZQZNOJ-UHFFFAOYSA-N 0.000 claims description 2
- YQCYLAFKFZPYMI-UHFFFAOYSA-N 2-chloro-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 YQCYLAFKFZPYMI-UHFFFAOYSA-N 0.000 claims description 2
- LCVGSLUHRUEFQF-UHFFFAOYSA-N 2-chloro-6-methylbenzo[c]chromene-6-carbonitrile Chemical compound C1=CC=C2C(C)(C#N)OC3=CC=C(Cl)C=C3C2=C1 LCVGSLUHRUEFQF-UHFFFAOYSA-N 0.000 claims description 2
- FMJCLWACXVWTEV-UHFFFAOYSA-N 2-fluoro-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 FMJCLWACXVWTEV-UHFFFAOYSA-N 0.000 claims description 2
- QRVIAYYVCKZNDL-UHFFFAOYSA-N 2-methoxy-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 QRVIAYYVCKZNDL-UHFFFAOYSA-N 0.000 claims description 2
- UXBZOIKFZKLKIP-UHFFFAOYSA-N 2-methoxy-6-methylbenzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C3=CC(OC)=CC=C3OC(C)(C(O)=O)C2=C1 UXBZOIKFZKLKIP-UHFFFAOYSA-N 0.000 claims description 2
- KNURFBBLRYWGPU-UHFFFAOYSA-N 2-nitro-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 KNURFBBLRYWGPU-UHFFFAOYSA-N 0.000 claims description 2
- VZVYWVAUYWGVHZ-UHFFFAOYSA-N 3-(2-nitro-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 VZVYWVAUYWGVHZ-UHFFFAOYSA-N 0.000 claims description 2
- OYDXACFITJOVNZ-UHFFFAOYSA-N 3-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC OYDXACFITJOVNZ-UHFFFAOYSA-N 0.000 claims description 2
- YWSOVFGKQVPUIQ-UHFFFAOYSA-N 6-methyl-2-(trifluoromethyl)benzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C(C)(C(O)=O)OC3=CC=C(C(F)(F)F)C=C3C2=C1 YWSOVFGKQVPUIQ-UHFFFAOYSA-N 0.000 claims description 2
- JMIGYWBRQKIVES-UHFFFAOYSA-N 8,9,10-trimethoxy-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC JMIGYWBRQKIVES-UHFFFAOYSA-N 0.000 claims description 2
- FJVKEZLUXBOCKN-UHFFFAOYSA-N 8,9,10-trimethoxy-4aH-benzo[c]chromene-6-carboxylic acid Chemical compound C(=O)(O)C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC FJVKEZLUXBOCKN-UHFFFAOYSA-N 0.000 claims description 2
- 208000023275 Autoimmune disease Diseases 0.000 claims description 2
- XKQPRSZAVGDHCL-UHFFFAOYSA-N CCOC(=O)CC1=C2C=C(C(=C(C2=C3C=CC=CC3O1)OC)OC)OC Chemical compound CCOC(=O)CC1=C2C=C(C(=C(C2=C3C=CC=CC3O1)OC)OC)OC XKQPRSZAVGDHCL-UHFFFAOYSA-N 0.000 claims description 2
- SIIOVVNXSLLNPZ-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)N Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)N SIIOVVNXSLLNPZ-UHFFFAOYSA-N 0.000 claims description 2
- GBWSHEMIFQPNLJ-UHFFFAOYSA-N CCOC(=O)CCC1=C2C=CC=CC2=C3C=CC=CC3O1 Chemical compound CCOC(=O)CCC1=C2C=CC=CC2=C3C=CC=CC3O1 GBWSHEMIFQPNLJ-UHFFFAOYSA-N 0.000 claims description 2
- IKBZPRCXSQVNBR-UHFFFAOYSA-N CN(C)CCOC(C1=C(C=CC=C2OC)C2=C2C(OC)=CC=CC2O1)=O Chemical compound CN(C)CCOC(C1=C(C=CC=C2OC)C2=C2C(OC)=CC=CC2O1)=O IKBZPRCXSQVNBR-UHFFFAOYSA-N 0.000 claims description 2
- 208000036142 Viral infection Diseases 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- NIZOTZNNXLNKLM-UHFFFAOYSA-N ethyl 1-methoxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2 NIZOTZNNXLNKLM-UHFFFAOYSA-N 0.000 claims description 2
- VWWPJVXYGMBXAG-UHFFFAOYSA-N ethyl 2-(2-amino-6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=C(N)C=C3C2=C1 VWWPJVXYGMBXAG-UHFFFAOYSA-N 0.000 claims description 2
- BQNXPAPVEKIAKD-UHFFFAOYSA-N ethyl 2-(2-chloro-6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=C(Cl)C=C3C2=C1 BQNXPAPVEKIAKD-UHFFFAOYSA-N 0.000 claims description 2
- KBPPCMIKRMJOTN-UHFFFAOYSA-N ethyl 2-(2-hydroxy-6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=C(O)C=C3C2=C1 KBPPCMIKRMJOTN-UHFFFAOYSA-N 0.000 claims description 2
- FZTFMWXRPGAARU-UHFFFAOYSA-N ethyl 2-(2-methoxy-6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=C(OC)C=C3C2=C1 FZTFMWXRPGAARU-UHFFFAOYSA-N 0.000 claims description 2
- ZBDGSLXMCDEBJX-UHFFFAOYSA-N ethyl 2-(6-methyl-2-nitrobenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=C([N+]([O-])=O)C=C3C2=C1 ZBDGSLXMCDEBJX-UHFFFAOYSA-N 0.000 claims description 2
- BECHFTVEYBAYDS-UHFFFAOYSA-N ethyl 2-(6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=CC=C3C2=C1 BECHFTVEYBAYDS-UHFFFAOYSA-N 0.000 claims description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 2
- 125000003386 piperidinyl group Chemical group 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 230000009385 viral infection Effects 0.000 claims description 2
- AOEMXUDOOQQGPB-UHFFFAOYSA-N 1-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1(CCNCC1)C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC AOEMXUDOOQQGPB-UHFFFAOYSA-N 0.000 claims 1
- MVHZPNRTVOFVFR-UHFFFAOYSA-N 2-(6-methylbenzo[c]chromen-6-yl)acetic acid Chemical compound C1=CC=C2C(C)(CC(O)=O)OC3=CC=CC=C3C2=C1 MVHZPNRTVOFVFR-UHFFFAOYSA-N 0.000 claims 1
- ZXHSUCREHJMPHD-UHFFFAOYSA-N 2-fluoro-6-methylbenzo[c]chromene-6-carbonitrile Chemical compound C1=CC=C2C(C)(C#N)OC3=CC=C(F)C=C3C2=C1 ZXHSUCREHJMPHD-UHFFFAOYSA-N 0.000 claims 1
- SIAOERNJDZOTGS-UHFFFAOYSA-N 2-fluoro-6-methylbenzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C(C)(C(O)=O)OC3=CC=C(F)C=C3C2=C1 SIAOERNJDZOTGS-UHFFFAOYSA-N 0.000 claims 1
- KVNZCTHDXSKLHU-UHFFFAOYSA-N 8,9,10-trimethoxy-6-methylbenzo[c]chromene-6-carbonitrile Chemical compound C12=CC=CC=C2OC(C#N)(C)C2=C1C(OC)=C(OC)C(OC)=C2 KVNZCTHDXSKLHU-UHFFFAOYSA-N 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- HYWCBRWUNBNLKN-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=C(C2=C3C(O1)C=CC=C3OC)OC Chemical compound CCOC(=O)CC1=C2C=CC=C(C2=C3C(O1)C=CC=C3OC)OC HYWCBRWUNBNLKN-UHFFFAOYSA-N 0.000 claims 1
- BUQYUMFJFYWCNZ-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)OC Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)OC BUQYUMFJFYWCNZ-UHFFFAOYSA-N 0.000 claims 1
- RBKYERKBABQOHN-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)[N+](=O)[O-] Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)[N+](=O)[O-] RBKYERKBABQOHN-UHFFFAOYSA-N 0.000 claims 1
- 206010061459 Gastrointestinal ulcer Diseases 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 150000001721 carbon Chemical group 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- OXEUNCGURIXJFN-UHFFFAOYSA-N ethyl 6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)(C)OC3=CC=CC=C3C2=C1 OXEUNCGURIXJFN-UHFFFAOYSA-N 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 119
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 80
- 239000000243 solution Substances 0.000 description 77
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 69
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 69
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 54
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 54
- 239000002904 solvent Substances 0.000 description 48
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 47
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- 239000011734 sodium Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 239000007787 solid Substances 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 9
- 238000007796 conventional method Methods 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 9
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- OLDVCFQSEZLGDG-UHFFFAOYSA-N 4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 OLDVCFQSEZLGDG-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- 150000001340 alkali metals Chemical class 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 229920006395 saturated elastomer Polymers 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 159000000000 sodium salts Chemical class 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 5
- 230000000026 anti-ulcerogenic effect Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 239000008096 xylene Substances 0.000 description 5
- OXJRPIUEFMWVOI-UHFFFAOYSA-N 2-(dimethylamino)ethyl 6h-benzo[c]chromene-6-carboxylate;hydrochloride Chemical compound Cl.C1=CC=C2C(C(=O)OCCN(C)C)OC3=CC=CC=C3C2=C1 OXJRPIUEFMWVOI-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 230000001262 anti-secretory effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- 230000020477 pH reduction Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- BKOBTLWVICWSLS-UHFFFAOYSA-N (1,10-dimethoxy-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC BKOBTLWVICWSLS-UHFFFAOYSA-N 0.000 description 3
- SDBIZCVPQROPLK-UHFFFAOYSA-N (1-methoxy-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2 SDBIZCVPQROPLK-UHFFFAOYSA-N 0.000 description 3
- KJDKUCNFFUYYPT-UHFFFAOYSA-N (2-fluoro-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 KJDKUCNFFUYYPT-UHFFFAOYSA-N 0.000 description 3
- GGJVQBAUKUVWHH-UHFFFAOYSA-N 1-(6h-benzo[c]chromen-6-yl)piperazine Chemical compound C1CNCCN1C1C2=CC=CC=C2C2=CC=CC=C2O1 GGJVQBAUKUVWHH-UHFFFAOYSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- RJFAXVGXCPTRGY-UHFFFAOYSA-N 2-(6h-benzo[c]chromen-6-yl)acetic acid Chemical compound C1=CC=C2C(CC(=O)O)OC3=CC=CC=C3C2=C1 RJFAXVGXCPTRGY-UHFFFAOYSA-N 0.000 description 3
- OLCFYPMYOULPBK-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-hydroxy-6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCCN(C)C)(C)OC3=CC=C(O)C=C3C2=C1 OLCFYPMYOULPBK-UHFFFAOYSA-N 0.000 description 3
- CRXBIPPQYDNHMV-UHFFFAOYSA-N 3-(4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 CRXBIPPQYDNHMV-UHFFFAOYSA-N 0.000 description 3
- VMKVAOCOAVSXOU-UHFFFAOYSA-N 4aH-benzo[c]chromene-6-carboxylic acid Chemical compound C(=O)(O)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 VMKVAOCOAVSXOU-UHFFFAOYSA-N 0.000 description 3
- ASWDRLNTSUWOGR-UHFFFAOYSA-N 4ah-benzo[c]chromen-6-ol Chemical compound C1=CC=CC2OC(O)=C(C=CC=C3)C3=C21 ASWDRLNTSUWOGR-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- AQMGAWVRJWRDST-UHFFFAOYSA-N CN(C)CCOC(=O)C1=C2C=C(C(=C(C2=C3C=CC=CC3O1)OC)OC)OC Chemical compound CN(C)CCOC(=O)C1=C2C=C(C(=C(C2=C3C=CC=CC3O1)OC)OC)OC AQMGAWVRJWRDST-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 230000001078 anti-cholinergic effect Effects 0.000 description 3
- 125000005605 benzo group Chemical group 0.000 description 3
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- ZJSXTBIJKUHALJ-UHFFFAOYSA-N ethyl 4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 ZJSXTBIJKUHALJ-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 230000002519 immonomodulatory effect Effects 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- OAWKRDGXAXOICR-UHFFFAOYSA-N (8-methoxy-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)OC OAWKRDGXAXOICR-UHFFFAOYSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- FNROQOBMEUVENM-UHFFFAOYSA-N 1-(4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1(CCNCC1)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 FNROQOBMEUVENM-UHFFFAOYSA-N 0.000 description 2
- JESTVXAWHHRSPL-UHFFFAOYSA-N 1-methoxy-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2 JESTVXAWHHRSPL-UHFFFAOYSA-N 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 2
- BVQTZIKFFVBZIE-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)-1-(4-methylpiperazin-1-yl)ethanone Chemical compound CN1CCN(CC1)C(=O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 BVQTZIKFFVBZIE-UHFFFAOYSA-N 0.000 description 2
- HERMERAXCUDXBT-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)-1-(4-phenylpiperazin-1-yl)ethanone Chemical compound C1(=CC=CC=C1)N1CCN(CC1)C(=O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 HERMERAXCUDXBT-UHFFFAOYSA-N 0.000 description 2
- FUXPVGBZUMXLEM-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)-2-hydroxyacetonitrile Chemical compound C(#N)C(C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2)O FUXPVGBZUMXLEM-UHFFFAOYSA-N 0.000 description 2
- BLRSIQPAVMVLPD-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)-N-methylethanamine Chemical compound CNCCC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 BLRSIQPAVMVLPD-UHFFFAOYSA-N 0.000 description 2
- DXLQXCHNCRJGMK-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)-N-tert-butyl-2-hydroxyacetamide Chemical compound C(C)(C)(C)NC(=O)C(C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2)O DXLQXCHNCRJGMK-UHFFFAOYSA-N 0.000 description 2
- AEOLZSCQBMHYJR-UHFFFAOYSA-N 2-(diethylamino)ethyl 4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)N(CCOC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2)CC AEOLZSCQBMHYJR-UHFFFAOYSA-N 0.000 description 2
- LTKHAXRQCIAKKM-UHFFFAOYSA-N 2-(diethylamino)ethyl 6h-benzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCCN(CC)CC)OC3=CC=CC=C3C2=C1 LTKHAXRQCIAKKM-UHFFFAOYSA-N 0.000 description 2
- HIMILVLDUPZPAK-UHFFFAOYSA-N 2-(trifluoromethyl)-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC(=C3)C(F)(F)F)C=CC=C2 HIMILVLDUPZPAK-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- WNHDOORHACMWJL-UHFFFAOYSA-N 2-chloro-6-methylbenzo[c]chromene-6-carboxamide Chemical compound C1=CC=C2C(C)(C(N)=O)OC3=CC=C(Cl)C=C3C2=C1 WNHDOORHACMWJL-UHFFFAOYSA-N 0.000 description 2
- KMWOTYHSVGWSDC-UHFFFAOYSA-N 2-fluoro-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 KMWOTYHSVGWSDC-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- TVKNXKLYVUVOCV-UHFFFAOYSA-N 6H-dibenzo[b,d]pyran-6-one Chemical compound C12=CC=CC=C2C(=O)OC2=C1C=CC=C2 TVKNXKLYVUVOCV-UHFFFAOYSA-N 0.000 description 2
- BHRGBYWGRLOFNP-UHFFFAOYSA-N 6h-benzo[c]chromen-6-ylmethanamine Chemical compound C1=CC=C2C(CN)OC3=CC=CC=C3C2=C1 BHRGBYWGRLOFNP-UHFFFAOYSA-N 0.000 description 2
- HGRBCPKTGIRABB-UHFFFAOYSA-N 8-nitro-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)[N+](=O)[O-] HGRBCPKTGIRABB-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HVYRAKDLMJBPLD-UHFFFAOYSA-N C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC Chemical compound C(=O)(O)CC1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC HVYRAKDLMJBPLD-UHFFFAOYSA-N 0.000 description 2
- NDHIPUSCCNCHRD-UHFFFAOYSA-N CC1=CC=CC2C1=C3C=CC=CC3=C(O2)C(=O)N4CCNCC4 Chemical compound CC1=CC=CC2C1=C3C=CC=CC3=C(O2)C(=O)N4CCNCC4 NDHIPUSCCNCHRD-UHFFFAOYSA-N 0.000 description 2
- VBWZWRIHIUUFRK-UHFFFAOYSA-N CCOC(=O)C(C1=C2C=CC=CC2=C3C=C(C=CC3O1)OC)O Chemical compound CCOC(=O)C(C1=C2C=CC=CC2=C3C=C(C=CC3O1)OC)O VBWZWRIHIUUFRK-UHFFFAOYSA-N 0.000 description 2
- RQHYKPKJTFSXHA-UHFFFAOYSA-N CN(C)CCOC(=O)CCC1=C2C=CC=CC2=C3C=CC=CC3O1 Chemical compound CN(C)CCOC(=O)CCC1=C2C=CC=CC2=C3C=CC=CC3O1 RQHYKPKJTFSXHA-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- 229910010082 LiAlH Inorganic materials 0.000 description 2
- 229910010084 LiAlH4 Inorganic materials 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- RSBDHRWJSBJOOH-UHFFFAOYSA-N N,N,1-trimethyl-4aH-benzo[c]chromene-6-carboxamide Chemical compound CN(C(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC=C2)C RSBDHRWJSBJOOH-UHFFFAOYSA-N 0.000 description 2
- UBKOIJTUBDNPBT-UHFFFAOYSA-N N-tert-butyl-2-hydroxy-2-(2-methoxy-4aH-benzo[c]chromen-6-yl)acetamide Chemical compound C(C)(C)(C)NC(=O)C(C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2)O UBKOIJTUBDNPBT-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 150000001266 acyl halides Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- YLZYMGHZMBPHQO-UHFFFAOYSA-N ethoxy(dimethoxy)alumane;sodium Chemical compound [Na].CCO[Al](OC)OC YLZYMGHZMBPHQO-UHFFFAOYSA-N 0.000 description 2
- WYQTWXNLTQOCPX-UHFFFAOYSA-N ethyl 1,10-dimethoxy-2-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3OC)C)C(=CC=C2)OC WYQTWXNLTQOCPX-UHFFFAOYSA-N 0.000 description 2
- LIMZYQVVWAXLCR-UHFFFAOYSA-N ethyl 1-methyl-2-(trifluoromethyl)-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3C)C(F)(F)F)C=CC=C2 LIMZYQVVWAXLCR-UHFFFAOYSA-N 0.000 description 2
- LHEXXKMATMKMKM-UHFFFAOYSA-N ethyl 1-methyl-2-nitro-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3C)[N+](=O)[O-])C=CC=C2 LHEXXKMATMKMKM-UHFFFAOYSA-N 0.000 description 2
- SQONFQMZBAMQLX-UHFFFAOYSA-N ethyl 2-(4aH-benzo[c]chromen-6-yl)-2-hydroxyacetate Chemical compound C(C)OC(=O)C(C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2)O SQONFQMZBAMQLX-UHFFFAOYSA-N 0.000 description 2
- CJACXSZGTLBCPB-UHFFFAOYSA-N ethyl 2-(8-hydroxy-4aH-benzo[c]chromen-6-yl)acetate Chemical compound C(C)OC(=O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)O CJACXSZGTLBCPB-UHFFFAOYSA-N 0.000 description 2
- SCRVTWSNSFUPRD-UHFFFAOYSA-N ethyl 2-chloro-1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3C)Cl)C=CC=C2 SCRVTWSNSFUPRD-UHFFFAOYSA-N 0.000 description 2
- GXRRLYFZYCKIOO-UHFFFAOYSA-N ethyl 2-chloro-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 GXRRLYFZYCKIOO-UHFFFAOYSA-N 0.000 description 2
- HTLNJPQVELGFLC-UHFFFAOYSA-N ethyl 2-fluoro-1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3C)F)C=CC=C2 HTLNJPQVELGFLC-UHFFFAOYSA-N 0.000 description 2
- HWKLUINQXFRPML-UHFFFAOYSA-N ethyl 2-hydroxy-2-(2-hydroxy-4aH-benzo[c]chromen-6-yl)acetate Chemical compound C(C)OC(=O)C(C1=C2C(=C3C(O1)C=CC(=C3)O)C=CC=C2)O HWKLUINQXFRPML-UHFFFAOYSA-N 0.000 description 2
- XCIKVZZWSJDCTQ-UHFFFAOYSA-N ethyl 2-hydroxy-2-(2-nitro-4aH-benzo[c]chromen-6-yl)acetate Chemical compound C(C)OC(=O)C(C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2)O XCIKVZZWSJDCTQ-UHFFFAOYSA-N 0.000 description 2
- NKCUWJJEXQDURT-UHFFFAOYSA-N ethyl 2-hydroxy-2-(6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(C(O)C(=O)OCC)(C)OC3=CC=CC=C3C2=C1 NKCUWJJEXQDURT-UHFFFAOYSA-N 0.000 description 2
- GXKRAVVFQFUILB-UHFFFAOYSA-N ethyl 2-hydroxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)O)C=CC=C2 GXKRAVVFQFUILB-UHFFFAOYSA-N 0.000 description 2
- CPGLBYHJLXWRAK-UHFFFAOYSA-N ethyl 2-methoxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 CPGLBYHJLXWRAK-UHFFFAOYSA-N 0.000 description 2
- QTGBOKPXIPOMMZ-UHFFFAOYSA-N ethyl 2-nitro-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 QTGBOKPXIPOMMZ-UHFFFAOYSA-N 0.000 description 2
- ZGUPMTCXPPKBKD-UHFFFAOYSA-N ethyl 3-(1,10-dimethoxy-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC ZGUPMTCXPPKBKD-UHFFFAOYSA-N 0.000 description 2
- GFKCLSGVFTUMGE-UHFFFAOYSA-N ethyl 3-(2-methoxy-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 GFKCLSGVFTUMGE-UHFFFAOYSA-N 0.000 description 2
- PIPZCUCONWYEOR-UHFFFAOYSA-N ethyl 3-(2-nitro-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 PIPZCUCONWYEOR-UHFFFAOYSA-N 0.000 description 2
- RXYFYDONJQPAGH-UHFFFAOYSA-N ethyl 3-(8-nitro-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)[N+](=O)[O-] RXYFYDONJQPAGH-UHFFFAOYSA-N 0.000 description 2
- UVYHUKIREHOHAG-UHFFFAOYSA-N ethyl 8,9,10-trimethoxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC UVYHUKIREHOHAG-UHFFFAOYSA-N 0.000 description 2
- ZWSDRNBPHCLPFS-UHFFFAOYSA-N ethyl 8-chloro-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)Cl ZWSDRNBPHCLPFS-UHFFFAOYSA-N 0.000 description 2
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000004997 halocarbonyl group Chemical group 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 230000000260 hypercholesteremic effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 2
- WNFLPUGNIFSQKC-UHFFFAOYSA-N n-tert-butyl-2-hydroxy-2-(6-methylbenzo[c]chromen-6-yl)acetamide Chemical compound C1=CC=C2C(C(O)C(=O)NC(C)(C)C)(C)OC3=CC=CC=C3C2=C1 WNFLPUGNIFSQKC-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000005968 oxazolinyl group Chemical class 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 125000004665 trialkylsilyl group Chemical group 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FYTOUMLHRJYCPK-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 1,6-dimethylbenzo[c]chromene-6-carboxylate Chemical compound CN1CCC(CC1)OC(=O)C1(C2=C(C3=C(O1)C=CC=C3C)C=CC=C2)C FYTOUMLHRJYCPK-UHFFFAOYSA-N 0.000 description 1
- VDZDQEAKFHXHLN-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound CN1CCC(CC1)OC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC=C2 VDZDQEAKFHXHLN-UHFFFAOYSA-N 0.000 description 1
- TWTRCHXRZUFAKM-UHFFFAOYSA-N (2-chloro-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 TWTRCHXRZUFAKM-UHFFFAOYSA-N 0.000 description 1
- VJVZPTPOYCJFNI-UHFFFAOYSA-M (2-ethoxy-2-oxoethyl)-triphenylphosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC(=O)OCC)C1=CC=CC=C1 VJVZPTPOYCJFNI-UHFFFAOYSA-M 0.000 description 1
- WBKJEQPPHSIAEU-UHFFFAOYSA-N (2-nitro-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 WBKJEQPPHSIAEU-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- UARRFRABOKMPPI-UHFFFAOYSA-N (8-chloro-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)Cl UARRFRABOKMPPI-UHFFFAOYSA-N 0.000 description 1
- ULKJPODRURAREU-UHFFFAOYSA-N (8-nitro-4aH-benzo[c]chromen-6-yl)methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)[N+](=O)[O-] ULKJPODRURAREU-UHFFFAOYSA-N 0.000 description 1
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 1
- 125000006828 (C2-C7) alkoxycarbonyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RPGNPABPUCGGJK-UHFFFAOYSA-N 1,10-dimethoxy-6-methylbenzo[c]chromene-6-carbonitrile Chemical compound O1C(C)(C#N)C2=CC=CC(OC)=C2C2=C1C=CC=C2OC RPGNPABPUCGGJK-UHFFFAOYSA-N 0.000 description 1
- QYMGRIFMUQCAJW-UHFFFAOYSA-N 1,2-dihydropyrazine Chemical compound C1NC=CN=C1 QYMGRIFMUQCAJW-UHFFFAOYSA-N 0.000 description 1
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical group C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 description 1
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 description 1
- LGHMBKQUZXROQC-UHFFFAOYSA-N 1-(2-methoxy-4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1(CCNCC1)C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 LGHMBKQUZXROQC-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- ATXISJSRKQTTDQ-UHFFFAOYSA-N 1-hydroxy-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC=C3O)C=CC=C2 ATXISJSRKQTTDQ-UHFFFAOYSA-N 0.000 description 1
- UALSZXGOIXOAKT-UHFFFAOYSA-N 1-methoxy-6-phenylbenzo[c]chromen-6-ol Chemical compound C12=CC=CC=C2C=2C(OC)=CC=CC=2OC1(O)C1=CC=CC=C1 UALSZXGOIXOAKT-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HXWMVOWPHCICHU-UHFFFAOYSA-N 1-methyl-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC=C2 HXWMVOWPHCICHU-UHFFFAOYSA-N 0.000 description 1
- ADIJZQJMFLNSPB-UHFFFAOYSA-N 2-(2-chloro-4aH-benzo[c]chromen-6-yl)-2-hydroxyacetic acid Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2)O ADIJZQJMFLNSPB-UHFFFAOYSA-N 0.000 description 1
- URXMIIHUVBNQJZ-UHFFFAOYSA-N 2-(2-fluoro-4aH-benzo[c]chromen-6-yl)-2-hydroxyacetonitrile Chemical compound C(#N)C(C1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2)O URXMIIHUVBNQJZ-UHFFFAOYSA-N 0.000 description 1
- LSJOCDCFCHXWPO-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)piperazine Chemical compound N1C(CNCC1)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 LSJOCDCFCHXWPO-UHFFFAOYSA-N 0.000 description 1
- DMMBLPZKWLHNQR-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)piperidine Chemical compound N1C(CCCC1)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 DMMBLPZKWLHNQR-UHFFFAOYSA-N 0.000 description 1
- IIAPPTCTESBMKY-UHFFFAOYSA-N 2-(4aH-benzo[c]chromen-6-yl)pyridine Chemical compound N1=C(C=CC=C1)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 IIAPPTCTESBMKY-UHFFFAOYSA-N 0.000 description 1
- JOJWMGRTHPQZLO-UHFFFAOYSA-N 2-(8-fluoro-4aH-benzo[c]chromen-6-yl)-2-hydroxyacetonitrile Chemical compound C(#N)C(C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F)O JOJWMGRTHPQZLO-UHFFFAOYSA-N 0.000 description 1
- DIWRLOXZKKKSNZ-UHFFFAOYSA-N 2-(dimethylamino)ethyl 1-hydroxy-6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCCN(C)C)(C)OC3=CC=CC(O)=C3C2=C1 DIWRLOXZKKKSNZ-UHFFFAOYSA-N 0.000 description 1
- SOKBHFRTVDAKFN-UHFFFAOYSA-N 2-(dimethylamino)ethyl 8-amino-6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=C(N)C=C2C(C(=O)OCCN(C)C)(C)OC3=CC=CC=C3C2=C1 SOKBHFRTVDAKFN-UHFFFAOYSA-N 0.000 description 1
- XRBYHUJSQCGKMD-UHFFFAOYSA-N 2-(dimethylamino)ethyl 8-hydroxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound CN(CCOC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)O)C XRBYHUJSQCGKMD-UHFFFAOYSA-N 0.000 description 1
- RLVMEUAEHUHMIE-UHFFFAOYSA-N 2-(dimethylamino)ethyl 8-hydroxy-6-methylbenzo[c]chromene-6-carboxylate Chemical compound C1=C(O)C=C2C(C(=O)OCCN(C)C)(C)OC3=CC=CC=C3C2=C1 RLVMEUAEHUHMIE-UHFFFAOYSA-N 0.000 description 1
- QIKSJUBVLGFOMO-UHFFFAOYSA-N 2-(tert-butylamino)-1-(1,10-dimethoxy-4aH-benzo[c]chromen-6-yl)ethanol Chemical compound OC(CNC(C)(C)C)C1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC QIKSJUBVLGFOMO-UHFFFAOYSA-N 0.000 description 1
- JLVZVGAIHNRTAR-UHFFFAOYSA-N 2-(tert-butylamino)-1-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)ethanol Chemical compound OC(CNC(C)(C)C)C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC JLVZVGAIHNRTAR-UHFFFAOYSA-N 0.000 description 1
- LOXPPXGTOPVBPH-UHFFFAOYSA-N 2-(tert-butylamino)-1-(8-fluoro-4aH-benzo[c]chromen-6-yl)ethanol Chemical compound OC(CNC(C)(C)C)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F LOXPPXGTOPVBPH-UHFFFAOYSA-N 0.000 description 1
- UUNIOFWUJYBVGQ-UHFFFAOYSA-N 2-amino-4-(3,4-dimethoxyphenyl)-10-fluoro-4,5,6,7-tetrahydrobenzo[1,2]cyclohepta[6,7-d]pyran-3-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1C1C(C#N)=C(N)OC2=C1CCCC1=CC=C(F)C=C12 UUNIOFWUJYBVGQ-UHFFFAOYSA-N 0.000 description 1
- MXMCJCSKOZXADM-UHFFFAOYSA-N 2-amino-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC(=C3)N)C=CC=C2 MXMCJCSKOZXADM-UHFFFAOYSA-N 0.000 description 1
- RLUPORGWEWZPSI-UHFFFAOYSA-N 2-chloro-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 RLUPORGWEWZPSI-UHFFFAOYSA-N 0.000 description 1
- BHSRIWQOJMIBDH-UHFFFAOYSA-N 2-hydroxy-2-(1-methoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2)O BHSRIWQOJMIBDH-UHFFFAOYSA-N 0.000 description 1
- LNTBNCKGECVODB-UHFFFAOYSA-N 2-hydroxy-2-(1-methoxy-4aH-benzo[c]chromen-6-yl)acetonitrile Chemical compound C(#N)C(C1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2)O LNTBNCKGECVODB-UHFFFAOYSA-N 0.000 description 1
- LUAFRODJNOVHCU-UHFFFAOYSA-N 2-hydroxy-2-(2-methoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2)O LUAFRODJNOVHCU-UHFFFAOYSA-N 0.000 description 1
- OUKVGUFTYSLFLR-UHFFFAOYSA-N 2-hydroxy-2-(2-methoxy-4aH-benzo[c]chromen-6-yl)acetonitrile Chemical compound C(#N)C(C1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2)O OUKVGUFTYSLFLR-UHFFFAOYSA-N 0.000 description 1
- OYFQVUIMCGXFKG-UHFFFAOYSA-N 2-hydroxy-2-(2-nitro-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2)O OYFQVUIMCGXFKG-UHFFFAOYSA-N 0.000 description 1
- PDYJQWCNLRBYDF-UHFFFAOYSA-N 2-hydroxy-2-(6-methylbenzo[c]chromen-6-yl)acetic acid Chemical compound C1=CC=C2C(C)(C(O)C(O)=O)OC3=CC=CC=C3C2=C1 PDYJQWCNLRBYDF-UHFFFAOYSA-N 0.000 description 1
- HWXMIYWSQYMKIM-UHFFFAOYSA-N 2-hydroxy-2-(6-methylbenzo[c]chromen-6-yl)acetonitrile Chemical compound C1=CC=C2C(C)(C(O)C#N)OC3=CC=CC=C3C2=C1 HWXMIYWSQYMKIM-UHFFFAOYSA-N 0.000 description 1
- CRVJSHUTNFOWDF-UHFFFAOYSA-N 2-hydroxy-2-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC)O CRVJSHUTNFOWDF-UHFFFAOYSA-N 0.000 description 1
- DGYZNLQAOXWGPY-UHFFFAOYSA-N 2-hydroxy-2-(8-methoxy-4aH-benzo[c]chromen-6-yl)acetic acid Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)OC)O DGYZNLQAOXWGPY-UHFFFAOYSA-N 0.000 description 1
- QGVLLOAOSMWUNQ-UHFFFAOYSA-N 2-hydroxy-2-(8-nitro-4aH-benzo[c]chromen-6-yl)acetonitrile Chemical compound C(#N)C(C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)[N+](=O)[O-])O QGVLLOAOSMWUNQ-UHFFFAOYSA-N 0.000 description 1
- ZDOKPJIUTRTUKZ-UHFFFAOYSA-N 2-hydroxy-4aH-benzo[c]chromene-6-carbonitrile Chemical compound C(#N)C1=C2C(=C3C(O1)C=CC(=C3)O)C=CC=C2 ZDOKPJIUTRTUKZ-UHFFFAOYSA-N 0.000 description 1
- DERQQMYJNVXASH-UHFFFAOYSA-N 2-nitro-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 DERQQMYJNVXASH-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- HNMMKNYSWWAHRB-UHFFFAOYSA-N 3-(1,10-dimethoxy-4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC HNMMKNYSWWAHRB-UHFFFAOYSA-N 0.000 description 1
- XKZZABDNWPPLEL-UHFFFAOYSA-N 3-(1,10-dimethoxy-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC XKZZABDNWPPLEL-UHFFFAOYSA-N 0.000 description 1
- CREIYAWTQFMCCY-UHFFFAOYSA-N 3-(1,10-dimethoxy-6-methylbenzo[c]chromen-6-yl)propanoic acid Chemical compound O1C(C)(CCC(O)=O)C2=CC=CC(OC)=C2C2=C1C=CC=C2OC CREIYAWTQFMCCY-UHFFFAOYSA-N 0.000 description 1
- IEULWWRVENJHSY-UHFFFAOYSA-N 3-(1-methoxy-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC=C3OC)C=CC=C2 IEULWWRVENJHSY-UHFFFAOYSA-N 0.000 description 1
- PFCQSEQKNOHILT-UHFFFAOYSA-N 3-(2-chloro-4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2 PFCQSEQKNOHILT-UHFFFAOYSA-N 0.000 description 1
- LHRIQLTZPLEFTK-UHFFFAOYSA-N 3-(2-fluoro-4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 LHRIQLTZPLEFTK-UHFFFAOYSA-N 0.000 description 1
- FNDVNAVHEKEGNX-UHFFFAOYSA-N 3-(2-methoxy-4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 FNDVNAVHEKEGNX-UHFFFAOYSA-N 0.000 description 1
- WRWCMEHOSXHBPX-UHFFFAOYSA-N 3-(2-methoxy-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC(=C3)OC)C=CC=C2 WRWCMEHOSXHBPX-UHFFFAOYSA-N 0.000 description 1
- PXUKQTWPDPPUMM-UHFFFAOYSA-N 3-(4aH-benzo[c]chromen-6-yl)pyridine Chemical compound N1=CC(=CC=C1)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 PXUKQTWPDPPUMM-UHFFFAOYSA-N 0.000 description 1
- MOVPINWLXHPUCV-UHFFFAOYSA-N 3-(6-methyl-8-nitrobenzo[c]chromen-6-yl)propanoic acid Chemical compound C1=C([N+]([O-])=O)C=C2C(C)(CCC(O)=O)OC3=CC=CC=C3C2=C1 MOVPINWLXHPUCV-UHFFFAOYSA-N 0.000 description 1
- COUOJLZZAXFYKD-UHFFFAOYSA-N 3-(8,9,10-trimethoxy-6-methylbenzo[c]chromen-6-yl)propanoic acid Chemical compound C12=CC=CC=C2OC(CCC(O)=O)(C)C2=C1C(OC)=C(OC)C(OC)=C2 COUOJLZZAXFYKD-UHFFFAOYSA-N 0.000 description 1
- BDNFHLOZLGIKDC-UHFFFAOYSA-N 3-(8-chloro-4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)Cl BDNFHLOZLGIKDC-UHFFFAOYSA-N 0.000 description 1
- OMFASESQJIRWIL-UHFFFAOYSA-N 3-(8-fluoro-4aH-benzo[c]chromen-6-yl)-N-methylpropan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F OMFASESQJIRWIL-UHFFFAOYSA-N 0.000 description 1
- BMUKVWZHOPJFJB-UHFFFAOYSA-N 3-(8-fluoro-4aH-benzo[c]chromen-6-yl)propanoic acid Chemical compound C(=O)(O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F BMUKVWZHOPJFJB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
- QPBXTFCCCGMJMP-UHFFFAOYSA-N 4aH-benzo[c]chromen-6-yl-(4-methylpiperazin-1-yl)methanone Chemical compound CN1CCN(CC1)C(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 QPBXTFCCCGMJMP-UHFFFAOYSA-N 0.000 description 1
- SBGDXCPQLBNREG-UHFFFAOYSA-N 4aH-benzo[c]chromen-6-ylmethanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 SBGDXCPQLBNREG-UHFFFAOYSA-N 0.000 description 1
- KDTQBESFYGHFDV-UHFFFAOYSA-N 4aH-benzo[c]chromene Chemical compound C1=CC=CC2OC=C(C=CC=C3)C3=C21 KDTQBESFYGHFDV-UHFFFAOYSA-N 0.000 description 1
- UGUACBPBFCFDRM-UHFFFAOYSA-N 4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC=C2 UGUACBPBFCFDRM-UHFFFAOYSA-N 0.000 description 1
- WAAVSFASCGQTGY-UHFFFAOYSA-N 6-(aminomethyl)-4aH-benzo[c]chromen-2-amine Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)N)C=CC=C2 WAAVSFASCGQTGY-UHFFFAOYSA-N 0.000 description 1
- YRQOYAJWVWIEHN-UHFFFAOYSA-N 6-(hydroxymethyl)benzo[c]chromene-6-carbonitrile Chemical compound C1=CC=C2C(CO)(C#N)OC3=CC=CC=C3C2=C1 YRQOYAJWVWIEHN-UHFFFAOYSA-N 0.000 description 1
- KOBICGCMDRHRRM-UHFFFAOYSA-N 6-(hydroxymethyl)benzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C(CO)(C(O)=O)OC3=CC=CC=C3C2=C1 KOBICGCMDRHRRM-UHFFFAOYSA-N 0.000 description 1
- CXRYQLQDODLKFF-UHFFFAOYSA-N 6-(methylamino)-4aH-benzo[c]chromen-8-ol Chemical compound CNC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)O CXRYQLQDODLKFF-UHFFFAOYSA-N 0.000 description 1
- HSDNNSADOHPUDU-UHFFFAOYSA-N 6-[2-(methylamino)ethyl]-4aH-benzo[c]chromen-1-ol Chemical compound CNCCC1=C2C(=C3C(O1)C=CC=C3O)C=CC=C2 HSDNNSADOHPUDU-UHFFFAOYSA-N 0.000 description 1
- YUNUCWDWTLXIPX-UHFFFAOYSA-N 6-[2-(methylamino)ethyl]-4aH-benzo[c]chromen-2-amine Chemical compound CNCCC1=C2C(=C3C(O1)C=CC(=C3)N)C=CC=C2 YUNUCWDWTLXIPX-UHFFFAOYSA-N 0.000 description 1
- OQGARAWXUGFMQT-UHFFFAOYSA-N 6-[2-(methylamino)ethyl]-4aH-benzo[c]chromen-8-ol Chemical compound CNCCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)O OQGARAWXUGFMQT-UHFFFAOYSA-N 0.000 description 1
- YEIMGVLKEYHGFP-UHFFFAOYSA-N 6-[3-(methylamino)propyl]-4aH-benzo[c]chromen-8-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)N YEIMGVLKEYHGFP-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- XYIFYHVMMVPQLO-UHFFFAOYSA-N 6-methyl-2-nitrobenzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C(C)(C(O)=O)OC3=CC=C([N+]([O-])=O)C=C3C2=C1 XYIFYHVMMVPQLO-UHFFFAOYSA-N 0.000 description 1
- FDLSYTBZTBKFRS-UHFFFAOYSA-N 6-methylbenzo[c]chromene-6-carboxylic acid Chemical compound C1=CC=C2C(C)(C(O)=O)OC3=CC=CC=C3C2=C1 FDLSYTBZTBKFRS-UHFFFAOYSA-N 0.000 description 1
- WQHAZYSCIDMBTQ-UHFFFAOYSA-N 6h-benzo[c]chromene-6-carbonitrile Chemical compound C1=CC=C2C(C#N)OC3=CC=CC=C3C2=C1 WQHAZYSCIDMBTQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- NXSXTNKWTCGEDB-UHFFFAOYSA-N 8-chloro-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)Cl NXSXTNKWTCGEDB-UHFFFAOYSA-N 0.000 description 1
- JEPGTZWLDQPEEV-UHFFFAOYSA-N 8-fluoro-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F JEPGTZWLDQPEEV-UHFFFAOYSA-N 0.000 description 1
- LDGOVGMRWGKPJC-UHFFFAOYSA-N 8-methoxy-4aH-benzo[c]chromene-6-carboxamide Chemical compound NC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)OC LDGOVGMRWGKPJC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000029483 Acquired immunodeficiency Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000428352 Amma Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 238000006218 Arndt-Eistert homologation reaction Methods 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 229910015845 BBr3 Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical group CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 1
- QVRCQOVJWOVYEP-UHFFFAOYSA-N C(=O)(O)C(C1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC)O Chemical compound C(=O)(O)C(C1=C2C(=C3C(O1)C=CC=C3OC)C(=CC=C2)OC)O QVRCQOVJWOVYEP-UHFFFAOYSA-N 0.000 description 1
- MERKZVKOPSQVDC-UHFFFAOYSA-N CC(C)(C)NC(=O)C(C1=C2C=CC=CC2=C3C=C(C=CC3O1)O)O Chemical compound CC(C)(C)NC(=O)C(C1=C2C=CC=CC2=C3C=C(C=CC3O1)O)O MERKZVKOPSQVDC-UHFFFAOYSA-N 0.000 description 1
- JSIFHEHQMCVOSX-UHFFFAOYSA-N CC(C1=C(C=CC=C2)C2=C(N)OC1C=C1)=C1Cl Chemical compound CC(C1=C(C=CC=C2)C2=C(N)OC1C=C1)=C1Cl JSIFHEHQMCVOSX-UHFFFAOYSA-N 0.000 description 1
- SJKIHTOLDJQNFR-UHFFFAOYSA-N CCOC(=O)C1=C2C=CC=CC2=C3C(O1)C=CC(=C3C)OC Chemical compound CCOC(=O)C1=C2C=CC=CC2=C3C(O1)C=CC(=C3C)OC SJKIHTOLDJQNFR-UHFFFAOYSA-N 0.000 description 1
- XONISNUCJMODHA-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C(O1)C=CC=C3O Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C(O1)C=CC=C3O XONISNUCJMODHA-UHFFFAOYSA-N 0.000 description 1
- BDDBYPAVPLQKLY-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)Cl Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)Cl BDDBYPAVPLQKLY-UHFFFAOYSA-N 0.000 description 1
- FKPOATYRXATJMW-UHFFFAOYSA-N CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)F Chemical compound CCOC(=O)CC1=C2C=CC=CC2=C3C=C(C=CC3O1)F FKPOATYRXATJMW-UHFFFAOYSA-N 0.000 description 1
- ZOLGCKFZGGTPEO-UHFFFAOYSA-N CCOC(=O)CCCC1=C2C=CC=CC2=C3C=CC=CC3O1 Chemical compound CCOC(=O)CCCC1=C2C=CC=CC2=C3C=CC=CC3O1 ZOLGCKFZGGTPEO-UHFFFAOYSA-N 0.000 description 1
- MNYHNSNSDLKVQP-UHFFFAOYSA-N CN(C)CCOC(=O)C1=C2C=C(C=CC2=C3C=CC=CC3O1)Cl Chemical compound CN(C)CCOC(=O)C1=C2C=C(C=CC2=C3C=CC=CC3O1)Cl MNYHNSNSDLKVQP-UHFFFAOYSA-N 0.000 description 1
- WPXWUPNLXXMPMH-UHFFFAOYSA-N CN(C)CCOC(=O)C1=C2C=C(C=CC2=C3C=CC=CC3O1)[N+](=O)[O-] Chemical compound CN(C)CCOC(=O)C1=C2C=C(C=CC2=C3C=CC=CC3O1)[N+](=O)[O-] WPXWUPNLXXMPMH-UHFFFAOYSA-N 0.000 description 1
- IXROSUXNUJUKEO-UHFFFAOYSA-N CN(C)CCOC(=O)C1=C2C=CC=CC2=C3C=C(C=CC3O1)O Chemical compound CN(C)CCOC(=O)C1=C2C=CC=CC2=C3C=C(C=CC3O1)O IXROSUXNUJUKEO-UHFFFAOYSA-N 0.000 description 1
- GNEJHEXSBGSMLE-UHFFFAOYSA-N CN(C)CCOC(=O)CC1=C2C=C(C=CC2=C3C=CC=CC3O1)N Chemical compound CN(C)CCOC(=O)CC1=C2C=C(C=CC2=C3C=CC=CC3O1)N GNEJHEXSBGSMLE-UHFFFAOYSA-N 0.000 description 1
- AEENVMWNPINWRP-UHFFFAOYSA-N CN(C)CCOC(=O)CC1=C2C=CC=CC2=C3C(O1)C=CC=C3O Chemical compound CN(C)CCOC(=O)CC1=C2C=CC=CC2=C3C(O1)C=CC=C3O AEENVMWNPINWRP-UHFFFAOYSA-N 0.000 description 1
- BEGFUEDAVVPSJE-UHFFFAOYSA-N CN(C)CCOC(C1=C(C=CC=C2)C2=C2C(O)=CC=CC2O1)=O Chemical compound CN(C)CCOC(C1=C(C=CC=C2)C2=C2C(O)=CC=CC2O1)=O BEGFUEDAVVPSJE-UHFFFAOYSA-N 0.000 description 1
- PKBKHZBONIVPJT-UHFFFAOYSA-N CN(C)CCOC(C1=C(C=CC=C2)C2=C2C=C(C(F)(F)F)C=CC2O1)=O Chemical compound CN(C)CCOC(C1=C(C=CC=C2)C2=C2C=C(C(F)(F)F)C=CC2O1)=O PKBKHZBONIVPJT-UHFFFAOYSA-N 0.000 description 1
- IPBHTAYVTUNOCC-UHFFFAOYSA-N CN(C)CCOC(CC(OC1C=C2)=C(C=CC=C3)C3=C1C=C2O)=O Chemical compound CN(C)CCOC(CC(OC1C=C2)=C(C=CC=C3)C3=C1C=C2O)=O IPBHTAYVTUNOCC-UHFFFAOYSA-N 0.000 description 1
- MOTAMVQXRWIMQD-UHFFFAOYSA-N CN(C)CCOC(CC1=C(C=C(C=C2)O)C2=C2C=CC=CC2O1)=O Chemical compound CN(C)CCOC(CC1=C(C=C(C=C2)O)C2=C2C=CC=CC2O1)=O MOTAMVQXRWIMQD-UHFFFAOYSA-N 0.000 description 1
- JVVLXRUNVBTPTA-UHFFFAOYSA-N CNCCCC1=C(C=C(C=C2)OC)C2=C2C=CC=CC2O1 Chemical compound CNCCCC1=C(C=C(C=C2)OC)C2=C2C=CC=CC2O1 JVVLXRUNVBTPTA-UHFFFAOYSA-N 0.000 description 1
- QBISQQYDGLCJHT-UHFFFAOYSA-N CNCCCC1=C2C=CC=CC2=C3C(O1)C=CC=C3OC Chemical compound CNCCCC1=C2C=CC=CC2=C3C(O1)C=CC=C3OC QBISQQYDGLCJHT-UHFFFAOYSA-N 0.000 description 1
- HBRRRXFBJWUANJ-UHFFFAOYSA-N COC1=CC=CC2OC(C(N)=O)=C(C=CC=C3OC)C3=C12 Chemical compound COC1=CC=CC2OC(C(N)=O)=C(C=CC=C3OC)C3=C12 HBRRRXFBJWUANJ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001275954 Cortinarius caperatus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019973 Herpes virus infection Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000005777 Lupus Nephritis Diseases 0.000 description 1
- 206010058143 Lupus vasculitis Diseases 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920003091 Methocel™ Polymers 0.000 description 1
- WNRIRMIMPIQVNM-UHFFFAOYSA-N N#CC(C1=C(C=CC=C2)C2=C2C=C(C(F)(F)F)C=CC2O1)O Chemical compound N#CC(C1=C(C=CC=C2)C2=C2C=C(C(F)(F)F)C=CC2O1)O WNRIRMIMPIQVNM-UHFFFAOYSA-N 0.000 description 1
- YUEKXPRIJFHDMU-UHFFFAOYSA-N N,1-dimethyl-4aH-benzo[c]chromene-6-carboxamide Chemical compound CNC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC=C2 YUEKXPRIJFHDMU-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- ROSVAFFGDRVJQB-UHFFFAOYSA-N N-methyl-3-(2-nitro-4aH-benzo[c]chromen-6-yl)propan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2 ROSVAFFGDRVJQB-UHFFFAOYSA-N 0.000 description 1
- SGCPAHFJTYTMIM-UHFFFAOYSA-N N-methyl-3-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)propan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC SGCPAHFJTYTMIM-UHFFFAOYSA-N 0.000 description 1
- WYGFBBNDDNKCMV-UHFFFAOYSA-N N-methyl-3-[2-(trifluoromethyl)-4aH-benzo[c]chromen-6-yl]propan-1-amine Chemical compound CNCCCC1=C2C(=C3C(O1)C=CC(=C3)C(F)(F)F)C=CC=C2 WYGFBBNDDNKCMV-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- CFFJTAFQEGUEMG-UHFFFAOYSA-N N-tert-butyl-2-(2-chloro-4aH-benzo[c]chromen-6-yl)-2-hydroxyacetamide Chemical compound C(C)(C)(C)NC(=O)C(C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2)O CFFJTAFQEGUEMG-UHFFFAOYSA-N 0.000 description 1
- AOIHLGDKFSPJEE-UHFFFAOYSA-N N-tert-butyl-2-hydroxy-2-(2-nitro-4aH-benzo[c]chromen-6-yl)acetamide Chemical compound C(C)(C)(C)NC(=O)C(C1=C2C(=C3C(O1)C=CC(=C3)[N+](=O)[O-])C=CC=C2)O AOIHLGDKFSPJEE-UHFFFAOYSA-N 0.000 description 1
- NQSBOMOVUVWIKT-UHFFFAOYSA-N N-tert-butyl-2-hydroxy-2-(8,9,10-trimethoxy-4aH-benzo[c]chromen-6-yl)acetamide Chemical compound C(C)(C)(C)NC(=O)C(C1=C2C(=C3C(O1)C=CC=C3)C(=C(C(=C2)OC)OC)OC)O NQSBOMOVUVWIKT-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- VDLWKBATDXRJCU-UHFFFAOYSA-N OC(C(O)=O)C(OC1C=C2)=C(C=CC=C3)C3=C1C=C2F Chemical compound OC(C(O)=O)C(OC1C=C2)=C(C=CC=C3)C3=C1C=C2F VDLWKBATDXRJCU-UHFFFAOYSA-N 0.000 description 1
- LIPICBUEPWCKID-UHFFFAOYSA-N OC(C(O)=O)C1=C(C=C(C=C2)Cl)C2=C2C=CC=CC2O1 Chemical compound OC(C(O)=O)C1=C(C=C(C=C2)Cl)C2=C2C=CC=CC2O1 LIPICBUEPWCKID-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- RSDOPYMFZBJHRL-UHFFFAOYSA-N Oxotremorine Chemical compound O=C1CCCN1CC#CCN1CCCC1 RSDOPYMFZBJHRL-UHFFFAOYSA-N 0.000 description 1
- 229910019213 POCl3 Inorganic materials 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 208000031951 Primary immunodeficiency Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 229910006124 SOCl2 Inorganic materials 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- JVVXZOOGOGPDRZ-SLFFLAALSA-N [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanamine Chemical compound NC[C@]1(C)CCC[C@]2(C)C3=CC=C(C(C)C)C=C3CC[C@H]21 JVVXZOOGOGPDRZ-SLFFLAALSA-N 0.000 description 1
- PUVNVFYRZCYMOR-UHFFFAOYSA-N [2-(trifluoromethyl)-4aH-benzo[c]chromen-6-yl]methanamine Chemical compound NCC1=C2C(=C3C(O1)C=CC(=C3)C(F)(F)F)C=CC=C2 PUVNVFYRZCYMOR-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 231100001015 blood dyscrasias Toxicity 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229950005499 carbon tetrachloride Drugs 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- NEWMBVVURODFOC-UHFFFAOYSA-N ethyl 1-hydroxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3O)C=CC=C2 NEWMBVVURODFOC-UHFFFAOYSA-N 0.000 description 1
- ARWRFRDCCAYWMU-UHFFFAOYSA-N ethyl 1-methoxy-2-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3OC)C)C=CC=C2 ARWRFRDCCAYWMU-UHFFFAOYSA-N 0.000 description 1
- LXLYSJNIPOIFTP-UHFFFAOYSA-N ethyl 1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC=C2 LXLYSJNIPOIFTP-UHFFFAOYSA-N 0.000 description 1
- SZUJOQVTKOEOAH-UHFFFAOYSA-N ethyl 2-(1-hydroxy-6-methylbenzo[c]chromen-6-yl)acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(C)OC3=CC=CC(O)=C3C2=C1 SZUJOQVTKOEOAH-UHFFFAOYSA-N 0.000 description 1
- DALXUHYPEAHKSP-UHFFFAOYSA-N ethyl 2-(2-chloro-4aH-benzo[c]chromen-6-yl)-2-hydroxyacetate Chemical compound C(C)OC(=O)C(C1=C2C(=C3C(O1)C=CC(=C3)Cl)C=CC=C2)O DALXUHYPEAHKSP-UHFFFAOYSA-N 0.000 description 1
- XHMJXIXIMPSDEI-UHFFFAOYSA-N ethyl 2-(8-amino-4aH-benzo[c]chromen-6-yl)acetate Chemical compound C(C)OC(=O)CC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)N XHMJXIXIMPSDEI-UHFFFAOYSA-N 0.000 description 1
- DLSQUOPFVHSXNU-UHFFFAOYSA-N ethyl 2-(trifluoromethyl)-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)C(F)(F)F)C=CC=C2 DLSQUOPFVHSXNU-UHFFFAOYSA-N 0.000 description 1
- IKPGMBOUBOGAQB-UHFFFAOYSA-N ethyl 2-[6-(hydroxymethyl)benzo[c]chromen-6-yl]acetate Chemical compound C1=CC=C2C(CC(=O)OCC)(CO)OC3=CC=CC=C3C2=C1 IKPGMBOUBOGAQB-UHFFFAOYSA-N 0.000 description 1
- YMYFRFCAXPYIKS-UHFFFAOYSA-N ethyl 2-amino-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)N)C=CC=C2 YMYFRFCAXPYIKS-UHFFFAOYSA-N 0.000 description 1
- RXSSQCPCNJSQSN-UHFFFAOYSA-N ethyl 2-fluoro-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC(=C3)F)C=CC=C2 RXSSQCPCNJSQSN-UHFFFAOYSA-N 0.000 description 1
- HNENSDXQNWFHOK-UHFFFAOYSA-N ethyl 3-(1-hydroxy-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3O)C=CC=C2 HNENSDXQNWFHOK-UHFFFAOYSA-N 0.000 description 1
- HYBIZPODNXRHLZ-UHFFFAOYSA-N ethyl 3-(1-hydroxy-6-methylbenzo[c]chromen-6-yl)propanoate Chemical compound C1=CC=C2C(CCC(=O)OCC)(C)OC3=CC=CC(O)=C3C2=C1 HYBIZPODNXRHLZ-UHFFFAOYSA-N 0.000 description 1
- OGEIFZONMQCWGO-UHFFFAOYSA-N ethyl 3-(2-chloro-6-methylbenzo[c]chromen-6-yl)propanoate Chemical compound C1=CC=C2C(CCC(=O)OCC)(C)OC3=CC=C(Cl)C=C3C2=C1 OGEIFZONMQCWGO-UHFFFAOYSA-N 0.000 description 1
- DZCYKADBTHYJHJ-UHFFFAOYSA-N ethyl 3-(2-hydroxy-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC(=C3)O)C=CC=C2 DZCYKADBTHYJHJ-UHFFFAOYSA-N 0.000 description 1
- TZWDPSHNMZGTQB-UHFFFAOYSA-N ethyl 3-(2-hydroxy-6-methylbenzo[c]chromen-6-yl)propanoate Chemical compound C1=CC=C2C(CCC(=O)OCC)(C)OC3=CC=C(O)C=C3C2=C1 TZWDPSHNMZGTQB-UHFFFAOYSA-N 0.000 description 1
- RXBUYTHFIJDNIW-UHFFFAOYSA-N ethyl 3-(8-amino-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)N RXBUYTHFIJDNIW-UHFFFAOYSA-N 0.000 description 1
- SRGPLDXLQRIUIT-UHFFFAOYSA-N ethyl 3-(8-amino-6-methylbenzo[c]chromen-6-yl)propanoate Chemical compound C1=C(N)C=C2C(CCC(=O)OCC)(C)OC3=CC=CC=C3C2=C1 SRGPLDXLQRIUIT-UHFFFAOYSA-N 0.000 description 1
- JANMRUIDDVVHJN-UHFFFAOYSA-N ethyl 3-(8-chloro-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)Cl JANMRUIDDVVHJN-UHFFFAOYSA-N 0.000 description 1
- LSSCDUCBEKTBKF-UHFFFAOYSA-N ethyl 3-(8-fluoro-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F LSSCDUCBEKTBKF-UHFFFAOYSA-N 0.000 description 1
- HUUYZLNNGKZCGX-UHFFFAOYSA-N ethyl 3-(8-methoxy-4aH-benzo[c]chromen-6-yl)propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)OC HUUYZLNNGKZCGX-UHFFFAOYSA-N 0.000 description 1
- VZYYKWMWCFGPPY-UHFFFAOYSA-N ethyl 3-[2-(trifluoromethyl)-4aH-benzo[c]chromen-6-yl]propanoate Chemical compound C(C)OC(=O)CCC1=C2C(=C3C(O1)C=CC(=C3)C(F)(F)F)C=CC=C2 VZYYKWMWCFGPPY-UHFFFAOYSA-N 0.000 description 1
- GEVXOIVTUUKEGA-UHFFFAOYSA-N ethyl 4-(6-methylbenzo[c]chromen-6-yl)butanoate Chemical compound C1=CC=C2C(CCCC(=O)OCC)(C)OC3=CC=CC=C3C2=C1 GEVXOIVTUUKEGA-UHFFFAOYSA-N 0.000 description 1
- HGUUQDBSPZNMDJ-UHFFFAOYSA-N ethyl 6h-benzo[c]chromene-6-carboxylate Chemical compound C1=CC=C2C(C(=O)OCC)OC3=CC=CC=C3C2=C1 HGUUQDBSPZNMDJ-UHFFFAOYSA-N 0.000 description 1
- RYNUNQAHILVUJV-UHFFFAOYSA-N ethyl 8-amino-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)N RYNUNQAHILVUJV-UHFFFAOYSA-N 0.000 description 1
- BLTAGMWWOOUANC-UHFFFAOYSA-N ethyl 8-chloro-1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC(=C2)Cl BLTAGMWWOOUANC-UHFFFAOYSA-N 0.000 description 1
- ZJPDEHZZMOAFRI-UHFFFAOYSA-N ethyl 8-fluoro-1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC(=C2)F ZJPDEHZZMOAFRI-UHFFFAOYSA-N 0.000 description 1
- YWWKTMFZPDTOAJ-UHFFFAOYSA-N ethyl 8-fluoro-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)F YWWKTMFZPDTOAJ-UHFFFAOYSA-N 0.000 description 1
- MDJBZIXIGSTUMR-UHFFFAOYSA-N ethyl 8-hydroxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)O MDJBZIXIGSTUMR-UHFFFAOYSA-N 0.000 description 1
- PYTILEJFASHMQU-UHFFFAOYSA-N ethyl 8-methoxy-1-methyl-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3C)C=CC(=C2)OC PYTILEJFASHMQU-UHFFFAOYSA-N 0.000 description 1
- TZYCMZFSTOBCMD-UHFFFAOYSA-N ethyl 8-methoxy-4aH-benzo[c]chromene-6-carboxylate Chemical compound C(C)OC(=O)C1=C2C(=C3C(O1)C=CC=C3)C=CC(=C2)OC TZYCMZFSTOBCMD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000144993 groups of animals Species 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910001867 inorganic solvent Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- PBMIETCUUSQZCG-UHFFFAOYSA-N n'-cyclohexylmethanediimine Chemical compound N=C=NC1CCCCC1 PBMIETCUUSQZCG-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000002731 stomach secretion inhibitor Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8033774 | 1980-10-20 | ||
GB8127718 | 1981-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8106167L SE8106167L (sv) | 1982-06-02 |
SE452009B true SE452009B (sv) | 1987-11-09 |
Family
ID=26277272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8106167A SE452009B (sv) | 1980-10-20 | 1981-10-19 | 6-substituerade 6h-dibenso/b,d/pyranderivat, forfarande for deras framstellning samt farmaceutisk komposition innehallande nemnda derivat |
Country Status (16)
Country | Link |
---|---|
US (1) | US4463001A (en, 2012) |
AT (1) | AT380245B (en, 2012) |
AU (1) | AU542121B2 (en, 2012) |
CA (1) | CA1235703A (en, 2012) |
CH (1) | CH651302A5 (en, 2012) |
DE (1) | DE3141387A1 (en, 2012) |
DK (1) | DK154974C (en, 2012) |
FI (1) | FI84824C (en, 2012) |
FR (1) | FR2492378B1 (en, 2012) |
HK (1) | HK9186A (en, 2012) |
IL (1) | IL64008A (en, 2012) |
IT (1) | IT1168040B (en, 2012) |
MY (1) | MY8600398A (en, 2012) |
NL (1) | NL191562C (en, 2012) |
SE (1) | SE452009B (en, 2012) |
SU (1) | SU1318163A3 (en, 2012) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2512024A1 (fr) * | 1981-08-27 | 1983-03-04 | Adir | Ethers tricycliques, leur preparation et les compositions pharmaceutiques les contenant |
GB8505756D0 (en) * | 1985-03-06 | 1985-04-11 | Erba Farmitalia | Tricyclic dibenzo condensed derivatives |
US5100909A (en) * | 1988-07-25 | 1992-03-31 | The Upjohn Company | Acetylenic imidazoles having central nervous system activity |
US5180736A (en) * | 1989-03-23 | 1993-01-19 | Warner-Lambert Company | Polycyclic amines useful as cerebrovascular agents |
US5202446A (en) * | 1990-05-23 | 1993-04-13 | E. I. Du Pont De Nemours And Company | Fluoridated monomers based on 9-phenyl-9-perfluoroalkylxanthene |
EP0757988A4 (en) * | 1994-04-27 | 2000-07-26 | Nippon Soda Co | IMIDAZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME |
ES2131020B1 (es) * | 1997-10-13 | 2000-03-01 | Lacer Sa | Derivados de benzofurano, dihidrobenzofunaro, dihidrobenzopirano y benzopirano como agentes antidepresivos. |
CN110092769B (zh) * | 2018-01-30 | 2022-09-20 | 华东师范大学 | 一种色烯衍生物及其合成方法和应用 |
JP2024503753A (ja) | 2021-01-27 | 2024-01-26 | ヴァンドリア エスアー | ウロリチン誘導体及びその使用方法 |
CN118812482B (zh) * | 2024-06-24 | 2025-02-07 | 中国水产科学研究院长江水产研究所 | 一种4H-苯并[b]吡喃类衍生物B78及其在抗中华鳖虹彩病毒上的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3799946A (en) * | 1972-03-13 | 1974-03-26 | Smithkline Corp | Dibenzo(b,d)pyran compounds |
US3856822A (en) * | 1973-07-18 | 1974-12-24 | Smithkline Corp | 3-alkenyl dibenzo (b,d)pyrans |
GB1464695A (en) * | 1974-06-24 | 1977-02-16 | Smithkline Corp | Dibenzo-b,c-pyrans and pharmaceutical compositions thereof |
-
1981
- 1981-10-01 US US06/307,597 patent/US4463001A/en not_active Expired - Lifetime
- 1981-10-06 IL IL64008A patent/IL64008A/xx not_active IP Right Cessation
- 1981-10-08 AU AU76161/81A patent/AU542121B2/en not_active Ceased
- 1981-10-12 FI FI813144A patent/FI84824C/fi not_active IP Right Cessation
- 1981-10-17 DE DE19813141387 patent/DE3141387A1/de active Granted
- 1981-10-19 DK DK461381A patent/DK154974C/da active
- 1981-10-19 CA CA000388273A patent/CA1235703A/en not_active Expired
- 1981-10-19 CH CH6665/81A patent/CH651302A5/de not_active IP Right Cessation
- 1981-10-19 SE SE8106167A patent/SE452009B/sv not_active IP Right Cessation
- 1981-10-19 IT IT24552/81A patent/IT1168040B/it active
- 1981-10-19 SU SU813346602A patent/SU1318163A3/ru active
- 1981-10-20 FR FR8119685A patent/FR2492378B1/fr not_active Expired
- 1981-10-20 NL NL8104749A patent/NL191562C/xx not_active IP Right Cessation
- 1981-10-20 AT AT0448781A patent/AT380245B/de not_active IP Right Cessation
-
1986
- 1986-02-05 HK HK91/86A patent/HK9186A/xx not_active IP Right Cessation
- 1986-12-30 MY MY398/86A patent/MY8600398A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HK9186A (en) | 1986-02-14 |
IT1168040B (it) | 1987-05-20 |
DK154974C (da) | 1989-06-12 |
DK154974B (da) | 1989-01-16 |
FI84824B (fi) | 1991-10-15 |
ATA448781A (de) | 1985-09-15 |
IL64008A0 (en) | 1982-01-31 |
FR2492378A1 (fr) | 1982-04-23 |
SE8106167L (sv) | 1982-06-02 |
AU7616181A (en) | 1982-09-09 |
NL191562C (nl) | 1995-09-19 |
FI813144L (fi) | 1982-04-21 |
DK461381A (da) | 1982-04-21 |
SU1318163A3 (ru) | 1987-06-15 |
NL8104749A (nl) | 1982-05-17 |
IT8124552A0 (it) | 1981-10-19 |
MY8600398A (en) | 1986-12-31 |
AU542121B2 (en) | 1985-02-07 |
IL64008A (en) | 1986-07-31 |
CH651302A5 (de) | 1985-09-13 |
AT380245B (de) | 1986-04-25 |
DE3141387A1 (de) | 1982-08-12 |
FI84824C (fi) | 1992-01-27 |
CA1235703A (en) | 1988-04-26 |
DE3141387C2 (en, 2012) | 1991-05-02 |
US4463001A (en) | 1984-07-31 |
FR2492378B1 (fr) | 1985-06-28 |
NL191562B (nl) | 1995-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4226878A (en) | Imidazole derivative | |
EP0004920B1 (de) | Carbazolyl-(4)-oxy-propanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
EP0024510B1 (en) | Phenoxypropyl amine derivatives, process for their preparation, and pharmaceutical compositions containing them | |
AU604737B2 (en) | N-phenylbutenamides with pharmaceutical properties | |
DE60031705T2 (de) | Salicylamid-derivate | |
SE452009B (sv) | 6-substituerade 6h-dibenso/b,d/pyranderivat, forfarande for deras framstellning samt farmaceutisk komposition innehallande nemnda derivat | |
DE68906200T2 (de) | Kondensierte pyrazol-3-oxo-propannitril-derivate und verfahren zu deren herstellung. | |
CH623809A5 (en) | Process for the preparation of pyrrolidones | |
US4430339A (en) | Substituted oxiranecarboxylic acids, their preparation and their use as medicaments | |
DE69719511T2 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
DE69132082T2 (de) | Pyridin-Derivate, Verfahren zu deren Herstellung und Anwendung | |
DK158460B (da) | Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer | |
US4301159A (en) | N-(Diethylaminoethyl)-2-alkoxy-benzamide derivatives | |
JPS5814435B2 (ja) | プロスタグランジン「きつ」抗剤としての4↓−ピロン誘導体 | |
DE69131057T2 (de) | 3-[1,Thiazolidinylbutyl-4-piperazinyl]-1H-Indazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente | |
JPH054383B2 (en, 2012) | ||
EP0230020B1 (en) | 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurans, a process for their preparation and their use as medicaments | |
GB2091721A (en) | 6-Substituted 6H- Dihydro[b,d]Pyran Derivatives and Process for their Preparation | |
WO1982003393A1 (en) | Ascorbic acid derivatives | |
IE51685B1 (en) | 6-substituted 6h-dibenzo(b,d)pyran derivatives and process for their preparation | |
WO1994008956A1 (en) | N-t-BUTYLANILINE ANALOG AND LIPID LEVEL DEPRESSANT CONTAINING THE SAME | |
US4377586A (en) | Diuretic 2,6-diaryl-4-pyridine carboxylic acids | |
DE3751063T2 (de) | Leukotrien-b4-analoge. | |
SE436878B (sv) | Forfarande for framstellning av metyl-2-(5-alkoxi)furyl-ketoner med verkan mot rinovirusinfektioner | |
DE2234706A1 (de) | Derivate von 9-oxo-13-trans-prostensaeureestern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8106167-3 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8106167-3 Format of ref document f/p: F |